|
|
|
|
| Advertisement |
Considering changing product access vendors? Watch this brief video to learn an effective 4-point methodology to optimize your program transition by addressing data conversion, implementation planning, stakeholder communications, and technology.
 Learn more |
| Special Feature |
|
|
Pharm Exec's Brand of the Year 2016
|
Pharm Exec's 10th annual Brand of the Year is Bristol-Myers Squibb's Opdivo, which has raced into the lead position in the treatment-shifting immuno-oncology space behind launches in three key cancers—melanoma, lung, and renal
... /Read more/ |
|
|
| Advertisement |
6 STEPS TO ENSURE SUCCESSFUL PATIENT ACCESS TO INNOVATIVE THERAPIES
LIVE WEBCAST: Thursday, May 26, 2016 at 4 pm BST | 5 pm CEST
 Free registration |
|
| Opinion |
|
|
Pharm Exec’s ANTI-BRAND of the Year
|
It would seem that the industry has much to be optimistic about in 2016. But a look at the winner and runner-up for our “Anti-Brand of the Year” award clarifies how many outside of the industry really see it
... /Read more/ |
|
|
| Advertisement |
Understanding the Chronic Disease Patient Journey in Emerging Markets
LIVE WEBCAST: Thursday, May 12, 2016, 11 am EDT / 4 pm BST /
5 pm CEST
Register now and join market research consultants Marc Yates and Rachel Howard for this complimentary webinar in which they will explore the chronic disease patient journey in emerging markets. Utilising local knowledge and detailed case studies, they will examine the patient journey from origination through to presentation, diagnosis, treatment choice, follow up and compliance and outline both the opportunities and challenges for global pharma at each stage.
 Free registration |
|
|
| Advertisement |
Precision asset valuation Leveraging insights from clinical and market access big data
On Demand
 Read more |
|
| Industry update |
| //Finding a replacement for GlaxoSmithKline CEO Andrew Witty, who is set to retire next year after nearly a decade in the job, will be “relatively expensive,” GSK Chairman Philip Hampton said last week.//Baxter International (Deerfield, IL) reported that Giuseppe Accogli has assumed the role of interim President, Renal, succeeding Jill Schaaf who resigned after two years in the role.//Aclaris Therapeutics, Inc. (Malvern, PA) appointed Kevin Scott as Vice President of Sales.//HarkerBIO (Buffalo, NY) appointed Artem Evdokimov, Ph.D. as Chief Executive Officer.// |
| Advertisement |
Medical science liaisons Optimizing their impact during product launch
On Demand
 Read more |
|
|
|
| |
|
|
